Research Article
Neopterin as a Marker of Response to Antiviral Therapy in Hepatitis C Virus Patients
Table 2
Neopterin and response rates to antiviral therapy in HCV patients (
).
| | Neopterin (nmol/L) (*) | Response rate | Odds ratio (95% CI) | Chi-square and value |
| | All genotypes: | | | | | <16 () | 51% | 3.73 (CI: 2.16–6.45) | Chi = 23.14 (df = 1), | |
≥16 () | 21% | | | | HCV 1 or 4: | | | | | <16 () | 42% | 3.20 (CI: 1.6–6.0) | Chi = 32.5 (df = 3), | |
≥16 () | 19% | | | | HCV 2 or 3: | | | | | <16 () | 74% | 4.60 (CI: 1.2–16.60) | Chi = 32.5 (df = 3), | |
≥16 () | 38% | | |
|
|
*N: number of observations.
|
